scispace - formally typeset
D

David J. Margolis

Researcher at University of Pennsylvania

Publications -  581
Citations -  74527

David J. Margolis is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Population & Atopic dermatitis. The author has an hindex of 97, co-authored 521 publications receiving 62556 citations. Previous affiliations of David J. Margolis include Rutgers University & Harvard University.

Papers
More filters
Journal ArticleDOI

Immunosuppressant medications and mortality in inflammatory bowel disease.

TL;DR: Patients treated with corticosteroids, but not thiopurines, are at increased risk of death, although this study could not clarify whether this was as a result of the medication or the underlying disease severity.
Journal ArticleDOI

Black/White Differences in Pressure Ulcer Incidence in Nursing Home Residents

TL;DR: To compare black and white nursing home residents with respect to the incidence of nursing home (NH)‐acquired pressure ulcers and to examine the role of resident characteristics and facility characteristics in explaining differences between the racial groups.

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: Quantifying the epidemiological transition

Christopher J L Murray, +611 more
TL;DR: The Global Burden of Disease Study 2013 (GBD 2013) aims to bring together all available epidemiological data using a coherent measurement framework, standardised estimation methods, and transparent data sources to enable comparisons of health loss over time and across causes, age-sex groups, and countries as discussed by the authors.
Journal ArticleDOI

Effect of Psoriasis Severity on Hypertension Control: A Population-Based Study in the United Kingdom

TL;DR: Among patients with hypertension, Psoriasis was associated with a greater likelihood of uncontrolled hypertension in a dose-dependent manner, with the greatest likelihood observed among those with moderate to severe psoriasis defined by 3% or more of the body surface area affected.